311
A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:May 9, 2023Active, not recruiting
Refractory Multiple Myeloma: 1471 Clinical Trials, Page 32 of 148
Hide Studies Not Open or Pending
312
A Study of Oprozomib, Pomalidomide, and Dexamethasone in Adults With Primary Refractory or Relapsed and Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:April 27, 2021Terminated
313
SL-401 in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:January 18, 2022Terminated
314
Isatuximab, Bendamustine, and Prednisone in Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:April 14, 2023Active, not recruiting
315
A Study to Investigate the Safety and Efficacy of TEG002 in Relapsed/Refractory Multiple Myeloma Patients
Condition(s):Multiple Myeloma, Refractory; Multiple Myeloma in Relapse; Multiple MyelomaLast Updated:September 8, 2022Active, not recruiting
316
Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM)
Condition(s):Multiple MyelomaLast Updated:August 29, 2022Recruiting
317
Ixazomib -Daratumumab Without Dexamethasone (IDara) in Elderly Relapse Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:July 8, 2019Recruiting
318
Study of Ibrutinib in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed/Relapsed and Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:March 16, 2020Completed
319
CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma
Condition(s):Recurrent Plasma Cell Myeloma; Refractory Plasma Cell MyelomaLast Updated:February 2, 2023Active, not recruiting
320
Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:June 24, 2013Completed